title: Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects.
authors.forename: M
authors.initials: M
authors.lastname: Bassetti
authors.forename: R
authors.initials: R
authors.lastname: Rosso
authors.forename: C
authors.initials: C
authors.lastname: Tosi
authors.forename: A
authors.initials: A
authors.lastname: DI Biagio
authors.forename: E
authors.initials: E
authors.lastname: Righi
authors.forename: C
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D000328:Adult; D001372:Aza Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D005260:Female; D024841:Fluoroquinolones; D015658:HIV Infections / Q000150:complications*; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin